The CRIPSR/Cas gene‐editing system—an immature but useful toolkit for experimental and clinical medicine

A Chinese scientist, Jiankui He, and his creation of the world's first genetically altered baby made headlines recently. As a newly developed gene‐editing technique, the CRISPR/Cas system should not be applied to human beings for reproductive purposes until it has been extensively tested. However, numerous experimental research studies in human somatic, germline cells, and even in embryos, have been conducted, which have shown CRISPR/Cas to be a useful tool for human genome editing and a potential therapeutic method for future clinical use.

[1]  J. Rinn,et al.  CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo , 2015, Nature Methods.

[2]  David V Schaffer,et al.  In vivo genome editing improves motor function and extends survival in a mouse model of ALS , 2017, Science Advances.

[3]  Max A. Horlbeck,et al.  Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation , 2014, Cell.

[4]  David R. Liu,et al.  Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage , 2016, Nature.

[5]  James J. Collins,et al.  Chromatin regulation at the frontier of synthetic biology , 2015, Nature Reviews Genetics.

[6]  Chun Jimmie Ye,et al.  CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells , 2016, Scientific Reports.

[7]  E. Rebar,et al.  Genome editing with engineered zinc finger nucleases , 2010, Nature Reviews Genetics.

[8]  Andreas Reinisch,et al.  Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6 , 2017, eLife.

[9]  R. Wagner,et al.  CRISPR: A Bacterial Immunity System Based on Small RNAs , 2012 .

[10]  Martin J. Aryee,et al.  In vivo CRISPR editing with no detectable genome-wide off-target mutations , 2018, Nature.

[11]  E. Lander,et al.  Development and Applications of CRISPR-Cas9 for Genome Engineering , 2014, Cell.

[12]  Kenichiro Hata,et al.  Targeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions , 2016, Nature Biotechnology.

[13]  Nipun Verma,et al.  CRISPR/Cas9-Based Engineering of the Epigenome. , 2017, Cell stem cell.

[14]  Jianhui Gong,et al.  Correction of a pathogenic gene mutation in human embryos , 2017, Nature.

[15]  Aviv Regev,et al.  RNA targeting with CRISPR–Cas13 , 2017, Nature.

[16]  R. Young,et al.  Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene , 2018, Cell.

[17]  F. Gage,et al.  CRISPR interference-based specific and efficient gene inactivation in the brain , 2018, Nature Neuroscience.

[18]  R. Tjian,et al.  Genomes in Focus: Development and Applications of CRISPR-Cas9 Imaging Technologies. , 2018, Angewandte Chemie.

[19]  Hui Yang,et al.  CRISPR/Cas9-mediated targeted chromosome elimination , 2017, Genome Biology.

[20]  Jennifer A. Doudna,et al.  CRISPR-Cas guides the future of genetic engineering , 2018, Science.

[21]  Anirvan Ghosh,et al.  Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes , 2017, Nature Biotechnology.

[22]  Haiyan Jiang,et al.  Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10 , 2019, Nature Medicine.

[23]  J. Keith Joung,et al.  TALENs: a widely applicable technology for targeted genome editing , 2012, Nature Reviews Molecular Cell Biology.

[24]  Mengmeng Gong,et al.  CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein , 2017, Molecular Genetics and Genomics.

[25]  J. Doudna,et al.  RNA-guided genetic silencing systems in bacteria and archaea , 2012, Nature.

[26]  C. R. Esteban,et al.  In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation , 2017, Cell.

[27]  Eugene V Koonin,et al.  Diversity, classification and evolution of CRISPR-Cas systems. , 2017, Current opinion in microbiology.

[28]  David Cyranoski,et al.  CRISPR gene-editing tested in a person for the first time , 2016, Nature.

[29]  Randall J. Platt,et al.  Therapeutic genome editing: prospects and challenges , 2015, Nature Medicine.

[30]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[31]  E. Olson,et al.  Publication : CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice , 2018 .

[32]  Luke A. Gilbert,et al.  CRISPR interference (CRISPRi) for sequence-specific control of gene expression , 2013, Nature Protocols.

[33]  Thorsten Bischler,et al.  CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9. , 2018, Molecular cell.

[34]  James N. Hughes,et al.  Inter-homologue repair in fertilized human eggs? , 2008, Nature.

[35]  Max J. Kellner,et al.  RNA editing with CRISPR-Cas13 , 2017, Science.

[36]  Chinese Academy of Sciences,et al.  Gene-edited babies: Chinese Academy of Medical Sciences’ response and action , 2019, The Lancet.

[37]  Christopher M. Vockley,et al.  Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators , 2015, Genome research.